vs
Quest Resource Holding Corp（QRHC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Quest Resource Holding Corp的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.7倍（$58.9M vs $35.5M），Quest Resource Holding Corp净利率更高（-2.8% vs -304.2%，领先301.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -15.8%），Quest Resource Holding Corp自由现金流更多（$1.0M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -10.0%）
Quest Resource Holding Corp是北美地区的可持续发展及废弃物管理服务提供商，面向商业、工业及零售客户提供一体化废弃物回收、资源化利用解决方案，帮助企业减少废弃物排放、降低运营成本，达成既定环保目标。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
QRHC vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $58.9M | $35.5M |
| 净利润 | $-1.7M | $-108.1M |
| 毛利率 | 15.5% | 59.8% |
| 营业利润率 | 0.9% | -304.8% |
| 净利率 | -2.8% | -304.2% |
| 营收同比 | -15.8% | 681.7% |
| 净利润同比 | 82.6% | 39.6% |
| 每股收益（稀释后） | $-0.08 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $58.9M | $35.5M | ||
| Q3 25 | $63.3M | $5.2M | ||
| Q2 25 | $59.5M | $19.2M | ||
| Q1 25 | $68.4M | $14.7M | ||
| Q4 24 | $70.0M | $4.5M | ||
| Q3 24 | $72.8M | $26.1M | ||
| Q2 24 | $73.1M | $14.4M | ||
| Q1 24 | $72.7M | $13.8M |
| Q4 25 | $-1.7M | $-108.1M | ||
| Q3 25 | $-1.3M | $-162.3M | ||
| Q2 25 | $-2.0M | $-171.9M | ||
| Q1 25 | $-10.4M | $-202.5M | ||
| Q4 24 | $-9.5M | $-178.9M | ||
| Q3 24 | $-3.4M | $-95.8M | ||
| Q2 24 | $-1.5M | $-97.5M | ||
| Q1 24 | $-655.0K | $-91.4M |
| Q4 25 | 15.5% | 59.8% | ||
| Q3 25 | 18.1% | -183.8% | ||
| Q2 25 | 18.5% | -4.9% | ||
| Q1 25 | 16.0% | -48.0% | ||
| Q4 24 | 15.3% | -181.4% | ||
| Q3 24 | 16.1% | 53.7% | ||
| Q2 24 | 18.5% | 36.2% | ||
| Q1 24 | 19.3% | 19.1% |
| Q4 25 | 0.9% | -304.8% | ||
| Q3 25 | 1.7% | -3327.6% | ||
| Q2 25 | 0.6% | -916.8% | ||
| Q1 25 | -11.9% | -1297.9% | ||
| Q4 24 | -10.3% | -4042.4% | ||
| Q3 24 | -1.3% | -377.1% | ||
| Q2 24 | 2.4% | -697.4% | ||
| Q1 24 | 2.6% | -698.4% |
| Q4 25 | -2.8% | -304.2% | ||
| Q3 25 | -2.1% | -3135.3% | ||
| Q2 25 | -3.3% | -894.2% | ||
| Q1 25 | -15.2% | -1373.3% | ||
| Q4 24 | -13.6% | -3935.5% | ||
| Q3 24 | -4.7% | -367.5% | ||
| Q2 24 | -2.1% | -676.6% | ||
| Q1 24 | -0.9% | -662.4% |
| Q4 25 | $-0.08 | $-0.17 | ||
| Q3 25 | $-0.06 | $-0.36 | ||
| Q2 25 | $-0.09 | $-0.41 | ||
| Q1 25 | $-0.50 | $-0.50 | ||
| Q4 24 | $-0.47 | $-0.56 | ||
| Q3 24 | $-0.16 | $-0.34 | ||
| Q2 24 | $-0.07 | $-0.40 | ||
| Q1 24 | $-0.03 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0M | $743.3M |
| 总债务越低越好 | $64.0M | $9.6M |
| 股东权益账面价值 | $40.5M | $1.1B |
| 总资产 | $145.6M | $1.5B |
| 负债/权益比越低杠杆越低 | 1.58× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $1.0M | $743.3M | ||
| Q3 25 | $1.1M | $659.8M | ||
| Q2 25 | $449.0K | $525.1M | ||
| Q1 25 | $1.4M | $500.5M | ||
| Q4 24 | $396.0K | $594.4M | ||
| Q3 24 | $1.1M | $427.6M | ||
| Q2 24 | $957.5K | $474.3M | ||
| Q1 24 | $581.1K | $296.3M |
| Q4 25 | $64.0M | $9.6M | ||
| Q3 25 | $65.4M | $11.9M | ||
| Q2 25 | $69.7M | $14.2M | ||
| Q1 25 | $74.1M | $16.4M | ||
| Q4 24 | $76.3M | $19.0M | ||
| Q3 24 | $71.9M | $20.5M | ||
| Q2 24 | $70.7M | $22.9M | ||
| Q1 24 | $68.5M | — |
| Q4 25 | $40.5M | $1.1B | ||
| Q3 25 | $42.0M | $1.0B | ||
| Q2 25 | $42.9M | $919.1M | ||
| Q1 25 | $44.4M | $933.9M | ||
| Q4 24 | $54.2M | $1.0B | ||
| Q3 24 | $62.8M | $524.6M | ||
| Q2 24 | $65.6M | $584.4M | ||
| Q1 24 | $66.3M | $401.2M |
| Q4 25 | $145.6M | $1.5B | ||
| Q3 25 | $149.3M | $1.4B | ||
| Q2 25 | $153.1M | $1.3B | ||
| Q1 25 | $165.7M | $1.3B | ||
| Q4 24 | $175.6M | $1.4B | ||
| Q3 24 | $178.2M | $726.5M | ||
| Q2 24 | $181.8M | $775.9M | ||
| Q1 24 | $179.0M | $557.8M |
| Q4 25 | 1.58× | 0.01× | ||
| Q3 25 | 1.56× | 0.01× | ||
| Q2 25 | 1.62× | 0.02× | ||
| Q1 25 | 1.67× | 0.02× | ||
| Q4 24 | 1.41× | 0.02× | ||
| Q3 24 | 1.15× | 0.04× | ||
| Q2 24 | 1.08× | 0.04× | ||
| Q1 24 | 1.03× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $1.0M | $-47.3M |
| 自由现金流率自由现金流/营收 | 1.7% | -133.1% |
| 资本支出强度资本支出/营收 | 0.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $9.3M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $1.1M | $-46.1M | ||
| Q3 25 | $5.7M | $-117.4M | ||
| Q2 25 | $3.9M | $-76.4M | ||
| Q1 25 | $-1.1M | $-132.0M | ||
| Q4 24 | $-4.8M | $-115.4M | ||
| Q3 24 | $-475.0K | $-59.2M | ||
| Q2 24 | $808.0K | $-82.2M | ||
| Q1 24 | $-1.7M | $-102.3M |
| Q4 25 | $1.0M | $-47.3M | ||
| Q3 25 | $5.6M | $-117.6M | ||
| Q2 25 | $3.9M | $-79.6M | ||
| Q1 25 | $-1.2M | $-133.8M | ||
| Q4 24 | $-5.2M | $-116.7M | ||
| Q3 24 | $-583.0K | $-63.8M | ||
| Q2 24 | $-1.4M | $-83.4M | ||
| Q1 24 | $-3.6M | $-109.0M |
| Q4 25 | 1.7% | -133.1% | ||
| Q3 25 | 8.9% | -2272.5% | ||
| Q2 25 | 6.5% | -413.9% | ||
| Q1 25 | -1.8% | -907.4% | ||
| Q4 24 | -7.4% | -2567.7% | ||
| Q3 24 | -0.8% | -244.6% | ||
| Q2 24 | -2.0% | -578.5% | ||
| Q1 24 | -4.9% | -789.9% |
| Q4 25 | 0.1% | 3.5% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | 0.0% | 16.4% | ||
| Q1 25 | 0.2% | 12.4% | ||
| Q4 24 | 0.6% | 28.6% | ||
| Q3 24 | 0.1% | 17.5% | ||
| Q2 24 | 3.1% | 8.2% | ||
| Q1 24 | 2.6% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
QRHC
| Services | $55.8M | 95% |
| Product Sales And Other | $3.1M | 5% |
RXRX
暂无分部数据
